newsfilter
← Latest News
GlobeNewswire·

I-Mab Announces Accelerated Givastomig Phase 1b Study Progress

Enrollment completed ahead of schedule in the first dose expansion cohortMomentum continues with first patient dosed in the second expansion cohortTopline results from the 40-patient dose expansion study expected in 1H